APO Research
Talk to an analyst

APO RESEARCH · REPORT

Plaque Psoriasis Treatment Medications

Compare research editions
View pricing & licenses

Selected research

Industry Research

Plaque Psoriasis Treatment Medications Industry Research Report 2026

28 December 2025138 pages

Choose your research edition.

Industry ResearchPlaque Psoriasis Treatment Medications Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Plaque Psoriasis Treatment Medications Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Plaque Psoriasis Treatment Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plaque Psoriasis Treatment Medications Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Plaque Psoriasis Treatment Medications Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Plaque Psoriasis Treatment Medications market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Plaque Psoriasis Treatment Medications is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Plaque Psoriasis Treatment Medications is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Plaque Psoriasis Treatment Medications is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Plaque Psoriasis Treatment Medications include Johnson & Johnson, Novartis, Merck, Eli Lilly, Pfizer, UCB, Organon, LEO Pharma and Galectin Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Plaque Psoriasis Treatment Medications market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Plaque Psoriasis Treatment Medications Market by Company

Johnson & Johnson

Novartis

Merck

Eli Lilly

Pfizer

UCB

Organon

LEO Pharma

Galectin Therapeutics

Dermira

Cellceutix

Biogen

Bayer

AstraZeneca

Amgen

Allergan

AbbVie

Plaque Psoriasis Treatment Medications Segment by Type

Non-biologic Drugs

Biologics

Small Molecule Drugs

Plaque Psoriasis Treatment Medications Segment by Application

Hospital

Clinic

Other

Plaque Psoriasis Treatment Medications Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plaque Psoriasis Treatment Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plaque Psoriasis Treatment Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plaque Psoriasis Treatment Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Plaque Psoriasis Treatment Medications manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Plaque Psoriasis Treatment Medications by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Plaque Psoriasis Treatment Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Plaque Psoriasis Treatment Medications Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Plaque Psoriasis Treatment Medications Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Plaque Psoriasis Treatment Medications Sales Market Share by Manufacturers (2021-2026) Table 8. Global Plaque Psoriasis Treatment Medications Revenue of Manufacturers (2021-2026) Table 9. Global Plaque Psoriasis Treatment Medications Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Plaque Psoriasis Treatment Medications Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Plaque Psoriasis Treatment Medications Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Plaque Psoriasis Treatment Medications, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Plaque Psoriasis Treatment Medications, Product Type & Application Table 14. Global Plaque Psoriasis Treatment Medications Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Plaque Psoriasis Treatment Medications by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Johnson & Johnson Company Information Table 19. Johnson & Johnson Business Overview Table 20. Johnson & Johnson Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Johnson & Johnson Plaque Psoriasis Treatment Medications Product Portfolio Table 22. Johnson & Johnson Recent Developments Table 23. Novartis Company Information Table 24. Novartis Business Overview Table 25. Novartis Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Novartis Plaque Psoriasis Treatment Medications Product Portfolio Table 27. Novartis Recent Developments Table 28. Merck Company Information Table 29. Merck Business Overview Table 30. Merck Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Merck Plaque Psoriasis Treatment Medications Product Portfolio Table 32. Merck Recent Developments Table 33. Eli Lilly Company Information Table 34. Eli Lilly Business Overview Table 35. Eli Lilly Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Eli Lilly Plaque Psoriasis Treatment Medications Product Portfolio Table 37. Eli Lilly Recent Developments Table 38. Pfizer Company Information Table 39. Pfizer Business Overview Table 40. Pfizer Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Pfizer Plaque Psoriasis Treatment Medications Product Portfolio Table 42. Pfizer Recent Developments Table 43. UCB Company Information Table 44. UCB Business Overview Table 45. UCB Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. UCB Plaque Psoriasis Treatment Medications Product Portfolio Table 47. UCB Recent Developments Table 48. Organon Company Information Table 49. Organon Business Overview Table 50. Organon Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Organon Plaque Psoriasis Treatment Medications Product Portfolio Table 52. Organon Recent Developments Table 53. LEO Pharma Company Information Table 54. LEO Pharma Business Overview Table 55. LEO Pharma Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. LEO Pharma Plaque Psoriasis Treatment Medications Product Portfolio Table 57. LEO Pharma Recent Developments Table 58. Galectin Therapeutics Company Information Table 59. Galectin Therapeutics Business Overview Table 60. Galectin Therapeutics Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Galectin Therapeutics Plaque Psoriasis Treatment Medications Product Portfolio Table 62. Galectin Therapeutics Recent Developments Table 63. Dermira Company Information Table 64. Dermira Business Overview Table 65. Dermira Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Dermira Plaque Psoriasis Treatment Medications Product Portfolio Table 67. Dermira Recent Developments Table 68. Cellceutix Company Information Table 69. Cellceutix Business Overview Table 70. Cellceutix Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Cellceutix Plaque Psoriasis Treatment Medications Product Portfolio Table 72. Cellceutix Recent Developments Table 73. Biogen Company Information Table 74. Biogen Business Overview Table 75. Biogen Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Biogen Plaque Psoriasis Treatment Medications Product Portfolio Table 77. Biogen Recent Developments Table 78. Bayer Company Information Table 79. Bayer Business Overview Table 80. Bayer Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Bayer Plaque Psoriasis Treatment Medications Product Portfolio Table 82. Bayer Recent Developments Table 83. AstraZeneca Company Information Table 84. AstraZeneca Business Overview Table 85. AstraZeneca Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. AstraZeneca Plaque Psoriasis Treatment Medications Product Portfolio Table 87. AstraZeneca Recent Developments Table 88. Amgen Company Information Table 89. Amgen Business Overview Table 90. Amgen Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Amgen Plaque Psoriasis Treatment Medications Product Portfolio Table 92. Amgen Recent Developments Table 93. Allergan Company Information Table 94. Allergan Business Overview Table 95. Allergan Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Allergan Plaque Psoriasis Treatment Medications Product Portfolio Table 97. Allergan Recent Developments Table 98. AbbVie Company Information Table 99. AbbVie Business Overview Table 100. AbbVie Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. AbbVie Plaque Psoriasis Treatment Medications Product Portfolio Table 102. AbbVie Recent Developments Table 103. Global Plaque Psoriasis Treatment Medications Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 104. Global Plaque Psoriasis Treatment Medications Sales by Region (2021-2026) & (K Units) Table 105. Global Plaque Psoriasis Treatment Medications Sales Market Share by Region (2021-2026) Table 106. Global Plaque Psoriasis Treatment Medications Sales by Region (2027-2032) & (K Units) Table 107. Global Plaque Psoriasis Treatment Medications Sales Market Share by Region (2027-2032) Table 108. Global Plaque Psoriasis Treatment Medications Revenue by Region (2021-2026) & (US$ Million) Table 109. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Region (2021-2026) Table 110. Global Plaque Psoriasis Treatment Medications Revenue by Region (2027-2032) & (US$ Million) Table 111. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Region (2027-2032) Table 112. North America Plaque Psoriasis Treatment Medications Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. North America Plaque Psoriasis Treatment Medications Sales by Country (2021-2026) & (K Units) Table 114. North America Plaque Psoriasis Treatment Medications Sales by Country (2027-2032) & (K Units) Table 115. North America Plaque Psoriasis Treatment Medications Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Plaque Psoriasis Treatment Medications Revenue by Country (2027-2032) & (US$ Million) Table 117. Europe Plaque Psoriasis Treatment Medications Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Europe Plaque Psoriasis Treatment Medications Sales by Country (2021-2026) & (K Units) Table 119. Europe Plaque Psoriasis Treatment Medications Sales by Country (2027-2032) & (K Units) Table 120. Europe Plaque Psoriasis Treatment Medications Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Plaque Psoriasis Treatment Medications Revenue by Country (2027-2032) & (US$ Million) Table 122. Asia Pacific Plaque Psoriasis Treatment Medications Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Asia Pacific Plaque Psoriasis Treatment Medications Sales by Country (2021-2026) & (K Units) Table 124. Asia Pacific Plaque Psoriasis Treatment Medications Sales by Country (2027-2032) & (K Units) Table 125. Asia Pacific Plaque Psoriasis Treatment Medications Revenue by Country (2021-2026) & (US$ Million) Table 126. Asia Pacific Plaque Psoriasis Treatment Medications Revenue by Country (2027-2032) & (US$ Million) Table 127. South America Plaque Psoriasis Treatment Medications Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. South America Plaque Psoriasis Treatment Medications Sales by Country (2021-2026) & (K Units) Table 129. South America Plaque Psoriasis Treatment Medications Sales by Country (2027-2032) & (K Units) Table 130. South America Plaque Psoriasis Treatment Medications Revenue by Country (2021-2026) & (US$ Million) Table 131. South America Plaque Psoriasis Treatment Medications Revenue by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Plaque Psoriasis Treatment Medications Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Middle East and Africa Plaque Psoriasis Treatment Medications Sales by Country (2021-2026) & (K Units) Table 134. Middle East and Africa Plaque Psoriasis Treatment Medications Sales by Country (2027-2032) & (K Units) Table 135. Middle East and Africa Plaque Psoriasis Treatment Medications Revenue by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Plaque Psoriasis Treatment Medications Revenue by Country (2027-2032) & (US$ Million) Table 137. Global Plaque Psoriasis Treatment Medications Sales by Type (2021-2026) & (K Units) Table 138. Global Plaque Psoriasis Treatment Medications Sales by Type (2027-2032) & (K Units) Table 139. Global Plaque Psoriasis Treatment Medications Sales Market Share by Type (2021-2026) Table 140. Global Plaque Psoriasis Treatment Medications Sales Market Share by Type (2027-2032) Table 141. Global Plaque Psoriasis Treatment Medications Revenue by Type (2021-2026) & (US$ Million) Table 142. Global Plaque Psoriasis Treatment Medications Revenue by Type (2027-2032) & (US$ Million) Table 143. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Type (2021-2026) Table 144. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Type (2027-2032) Table 145. Global Plaque Psoriasis Treatment Medications Price by Type (2021-2026) & (US$/Unit) Table 146. Global Plaque Psoriasis Treatment Medications Price by Type (2027-2032) & (US$/Unit) Table 147. Global Plaque Psoriasis Treatment Medications Sales by Application (2021-2026) & (K Units) Table 148. Global Plaque Psoriasis Treatment Medications Sales by Application (2027-2032) & (K Units) Table 149. Global Plaque Psoriasis Treatment Medications Sales Market Share by Application (2021-2026) Table 150. Global Plaque Psoriasis Treatment Medications Sales Market Share by Application (2027-2032) Table 151. Global Plaque Psoriasis Treatment Medications Revenue by Application (2021-2026) & (US$ Million) Table 152. Global Plaque Psoriasis Treatment Medications Revenue by Application (2027-2032) & (US$ Million) Table 153. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Application (2021-2026) Table 154. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Application (2027-2032) Table 155. Global Plaque Psoriasis Treatment Medications Price by Application (2021-2026) & (US$/Unit) Table 156. Global Plaque Psoriasis Treatment Medications Price by Application (2027-2032) & (US$/Unit) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Plaque Psoriasis Treatment Medications Distributors List Table 160. Plaque Psoriasis Treatment Medications Customers List Table 161. Plaque Psoriasis Treatment Medications Industry Trends Table 162. Plaque Psoriasis Treatment Medications Industry Drivers Table 163. Plaque Psoriasis Treatment Medications Industry Restraints Table 164. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Plaque Psoriasis Treatment Medications Product Image Figure 5. Global Plaque Psoriasis Treatment Medications Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Plaque Psoriasis Treatment Medications Market Size (2021-2032) & (US$ Million) Figure 7. Global Plaque Psoriasis Treatment Medications Sales (2021-2032) & (K Units) Figure 8. Global Plaque Psoriasis Treatment Medications Average Price (US$/Unit) & (2021-2032) Figure 9. Non-biologic Drugs Product Image Figure 10. Biologics Product Image Figure 11. Small Molecule Drugs Product Image Figure 12. Hospital Product Image Figure 13. Clinic Product Image Figure 14. Other Product Image Figure 15. Global Plaque Psoriasis Treatment Medications Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Plaque Psoriasis Treatment Medications, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Plaque Psoriasis Treatment Medications Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Plaque Psoriasis Treatment Medications Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Plaque Psoriasis Treatment Medications Sales by Region in 2025 Figure 21. Global Plaque Psoriasis Treatment Medications Revenue by Region in 2025 Figure 22. North America Plaque Psoriasis Treatment Medications Market Size by Country in 2025 Figure 23. North America Plaque Psoriasis Treatment Medications Sales Market Share by Country (2021-2032) Figure 24. North America Plaque Psoriasis Treatment Medications Revenue Market Share by Country (2021-2032) Figure 25. United States Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Plaque Psoriasis Treatment Medications Market Size by Country in 2025 Figure 29. Europe Plaque Psoriasis Treatment Medications Sales Market Share by Country (2021-2032) Figure 30. Europe Plaque Psoriasis Treatment Medications Revenue Market Share by Country (2021-2032) Figure 31. Germany Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Plaque Psoriasis Treatment Medications Market Size by Country in 2025 Figure 42. Asia Pacific Plaque Psoriasis Treatment Medications Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Plaque Psoriasis Treatment Medications Revenue Market Share by Country (2021-2032) Figure 44. China Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Plaque Psoriasis Treatment Medications Market Size by Country in 2025 Figure 53. South America Plaque Psoriasis Treatment Medications Sales Market Share by Country (2021-2032) Figure 54. South America Plaque Psoriasis Treatment Medications Revenue Market Share by Country (2021-2032) Figure 55. Brazil Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Plaque Psoriasis Treatment Medications Market Size by Country in 2025 Figure 59. Middle East and Africa Plaque Psoriasis Treatment Medications Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Plaque Psoriasis Treatment Medications Revenue Market Share by Country (2021-2032) Figure 61. Egypt Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Plaque Psoriasis Treatment Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Plaque Psoriasis Treatment Medications Sales Market Share by Type (2021-2032) Figure 67. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Type (2021-2032) Figure 68. Global Plaque Psoriasis Treatment Medications Price (US$/Unit) by Type (2021-2032) Figure 69. Global Plaque Psoriasis Treatment Medications Sales Market Share by Application (2021-2032) Figure 70. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Application (2021-2032) Figure 71. Global Plaque Psoriasis Treatment Medications Price (US$/Unit) by Application (2021-2032) Figure 72. Plaque Psoriasis Treatment Medications Value Chain Figure 73. Plaque Psoriasis Treatment Medications Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Plaque Psoriasis Treatment Medications Industry Opportunities and Challenges

Scope & coverage.

Types
  • Non-biologic Drugs
  • Biologics
  • Small Molecule Drugs
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Johnson & Johnson
  • Novartis
  • Merck
  • Eli Lilly
  • Pfizer
  • UCB
  • Organon
  • LEO Pharma
  • Galectin Therapeutics
  • Dermira
  • Cellceutix
  • Biogen
  • Bayer
  • AstraZeneca
  • Amgen
  • Allergan
  • AbbVie

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Plaque Psoriasis Treatment Medications Market Size (2021-2032)
  4. 2.2.2 Global Plaque Psoriasis Treatment Medications Sales (2021-2032)
  5. 2.2.3 Global Plaque Psoriasis Treatment Medications Market Average Price (2021-2032)
  6. 2.3 Plaque Psoriasis Treatment Medications by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Non-biologic Drugs
  9. 2.3.3 Biologics
  10. 2.3.4 Small Molecule Drugs
  11. 2.4 Plaque Psoriasis Treatment Medications by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Hospital
  14. 2.4.3 Clinic
  15. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Plaque Psoriasis Treatment Medications Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Plaque Psoriasis Treatment Medications Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Plaque Psoriasis Treatment Medications Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Plaque Psoriasis Treatment Medications Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Plaque Psoriasis Treatment Medications Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Plaque Psoriasis Treatment Medications, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Plaque Psoriasis Treatment Medications, Product Type & Application
  8. 3.8 Global Manufacturers of Plaque Psoriasis Treatment Medications, Established Date
  9. 3.9 Global Plaque Psoriasis Treatment Medications Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Johnson & Johnson
  2. 4.1.1 Johnson & Johnson Company Information
  3. 4.1.2 Johnson & Johnson Business Overview
  4. 4.1.3 Johnson & Johnson Plaque Psoriasis Treatment Medications Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Johnson & Johnson Plaque Psoriasis Treatment Medications Product Portfolio
  6. 4.1.5 Johnson & Johnson Recent Developments
  7. 4.2 Novartis
  8. 4.2.1 Novartis Company Information
  9. 4.2.2 Novartis Business Overview
  10. 4.2.3 Novartis Plaque Psoriasis Treatment Medications Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Novartis Plaque Psoriasis Treatment Medications Product Portfolio
  12. 4.2.5 Novartis Recent Developments
  13. 4.3 Merck
  14. 4.3.1 Merck Company Information
  15. 4.3.2 Merck Business Overview
  16. 4.3.3 Merck Plaque Psoriasis Treatment Medications Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Merck Plaque Psoriasis Treatment Medications Product Portfolio
  18. 4.3.5 Merck Recent Developments
  19. 4.4 Eli Lilly
  20. 4.4.1 Eli Lilly Company Information
  21. 4.4.2 Eli Lilly Business Overview
  22. 4.4.3 Eli Lilly Plaque Psoriasis Treatment Medications Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Eli Lilly Plaque Psoriasis Treatment Medications Product Portfolio
  24. 4.4.5 Eli Lilly Recent Developments
  25. 4.5 Pfizer
  26. 4.5.1 Pfizer Company Information
  27. 4.5.2 Pfizer Business Overview
  28. 4.5.3 Pfizer Plaque Psoriasis Treatment Medications Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Pfizer Plaque Psoriasis Treatment Medications Product Portfolio
  30. 4.5.5 Pfizer Recent Developments
  31. 4.6 UCB
  32. 4.6.1 UCB Company Information
  33. 4.6.2 UCB Business Overview
  34. 4.6.3 UCB Plaque Psoriasis Treatment Medications Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 UCB Plaque Psoriasis Treatment Medications Product Portfolio
  36. 4.6.5 UCB Recent Developments
  37. 4.7 Organon
  38. 4.7.1 Organon Company Information
  39. 4.7.2 Organon Business Overview
  40. 4.7.3 Organon Plaque Psoriasis Treatment Medications Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Organon Plaque Psoriasis Treatment Medications Product Portfolio
  42. 4.7.5 Organon Recent Developments
  43. 4.8 LEO Pharma
  44. 4.8.1 LEO Pharma Company Information
  45. 4.8.2 LEO Pharma Business Overview
  46. 4.8.3 LEO Pharma Plaque Psoriasis Treatment Medications Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 LEO Pharma Plaque Psoriasis Treatment Medications Product Portfolio
  48. 4.8.5 LEO Pharma Recent Developments
  49. 4.9 Galectin Therapeutics
  50. 4.9.1 Galectin Therapeutics Company Information
  51. 4.9.2 Galectin Therapeutics Business Overview
  52. 4.9.3 Galectin Therapeutics Plaque Psoriasis Treatment Medications Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Galectin Therapeutics Plaque Psoriasis Treatment Medications Product Portfolio
  54. 4.9.5 Galectin Therapeutics Recent Developments
  55. 4.10 Dermira
  56. 4.10.1 Dermira Company Information
  57. 4.10.2 Dermira Business Overview
  58. 4.10.3 Dermira Plaque Psoriasis Treatment Medications Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Dermira Plaque Psoriasis Treatment Medications Product Portfolio
  60. 4.10.5 Dermira Recent Developments
  61. 4.11 Cellceutix
  62. 4.11.1 Cellceutix Company Information
  63. 4.11.2 Cellceutix Business Overview
  64. 4.11.3 Cellceutix Plaque Psoriasis Treatment Medications Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Cellceutix Plaque Psoriasis Treatment Medications Product Portfolio
  66. 4.11.5 Cellceutix Recent Developments
  67. 4.12 Biogen
  68. 4.12.1 Biogen Company Information
  69. 4.12.2 Biogen Business Overview
  70. 4.12.3 Biogen Plaque Psoriasis Treatment Medications Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Biogen Plaque Psoriasis Treatment Medications Product Portfolio
  72. 4.12.5 Biogen Recent Developments
  73. 4.13 Bayer
  74. 4.13.1 Bayer Company Information
  75. 4.13.2 Bayer Business Overview
  76. 4.13.3 Bayer Plaque Psoriasis Treatment Medications Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Bayer Plaque Psoriasis Treatment Medications Product Portfolio
  78. 4.13.5 Bayer Recent Developments
  79. 4.14 AstraZeneca
  80. 4.14.1 AstraZeneca Company Information
  81. 4.14.2 AstraZeneca Business Overview
  82. 4.14.3 AstraZeneca Plaque Psoriasis Treatment Medications Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 AstraZeneca Plaque Psoriasis Treatment Medications Product Portfolio
  84. 4.14.5 AstraZeneca Recent Developments
  85. 4.15 Amgen
  86. 4.15.1 Amgen Company Information
  87. 4.15.2 Amgen Business Overview
  88. 4.15.3 Amgen Plaque Psoriasis Treatment Medications Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Amgen Plaque Psoriasis Treatment Medications Product Portfolio
  90. 4.15.5 Amgen Recent Developments
  91. 4.16 Allergan
  92. 4.16.1 Allergan Company Information
  93. 4.16.2 Allergan Business Overview
  94. 4.16.3 Allergan Plaque Psoriasis Treatment Medications Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Allergan Plaque Psoriasis Treatment Medications Product Portfolio
  96. 4.16.5 Allergan Recent Developments
  97. 4.17 AbbVie
  98. 4.17.1 AbbVie Company Information
  99. 4.17.2 AbbVie Business Overview
  100. 4.17.3 AbbVie Plaque Psoriasis Treatment Medications Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 AbbVie Plaque Psoriasis Treatment Medications Product Portfolio
  102. 4.17.5 AbbVie Recent Developments
5 Global Plaque Psoriasis Treatment Medications Market Scenario by Region
  1. 5.1 Global Plaque Psoriasis Treatment Medications Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Plaque Psoriasis Treatment Medications Sales by Region: 2021-2032
  3. 5.2.1 Global Plaque Psoriasis Treatment Medications Sales by Region: 2021-2026
  4. 5.2.2 Global Plaque Psoriasis Treatment Medications Sales by Region: 2027-2032
  5. 5.3 Global Plaque Psoriasis Treatment Medications Revenue by Region: 2021-2032
  6. 5.3.1 Global Plaque Psoriasis Treatment Medications Revenue by Region: 2021-2026
  7. 5.3.2 Global Plaque Psoriasis Treatment Medications Revenue by Region: 2027-2032
  8. 5.4 North America Plaque Psoriasis Treatment Medications Market Facts & Figures by Country
  9. 5.4.1 North America Plaque Psoriasis Treatment Medications Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Plaque Psoriasis Treatment Medications Sales by Country (2021-2032)
  11. 5.4.3 North America Plaque Psoriasis Treatment Medications Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Plaque Psoriasis Treatment Medications Market Facts & Figures by Country
  16. 5.5.1 Europe Plaque Psoriasis Treatment Medications Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Plaque Psoriasis Treatment Medications Sales by Country (2021-2032)
  18. 5.5.3 Europe Plaque Psoriasis Treatment Medications Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Plaque Psoriasis Treatment Medications Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Plaque Psoriasis Treatment Medications Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Plaque Psoriasis Treatment Medications Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Plaque Psoriasis Treatment Medications Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Plaque Psoriasis Treatment Medications Market Facts & Figures by Country
  41. 5.7.1 South America Plaque Psoriasis Treatment Medications Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Plaque Psoriasis Treatment Medications Sales by Country (2021-2032)
  43. 5.7.3 South America Plaque Psoriasis Treatment Medications Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Plaque Psoriasis Treatment Medications Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Plaque Psoriasis Treatment Medications Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Plaque Psoriasis Treatment Medications Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Plaque Psoriasis Treatment Medications Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Plaque Psoriasis Treatment Medications Sales by Type (2021-2032)
  2. 6.1.1 Global Plaque Psoriasis Treatment Medications Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Plaque Psoriasis Treatment Medications Sales Market Share by Type (2021-2032)
  4. 6.2 Global Plaque Psoriasis Treatment Medications Revenue by Type (2021-2032)
  5. 6.2.1 Global Plaque Psoriasis Treatment Medications Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Plaque Psoriasis Treatment Medications Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Plaque Psoriasis Treatment Medications Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Plaque Psoriasis Treatment Medications Sales by Application (2021-2032)
  2. 7.1.1 Global Plaque Psoriasis Treatment Medications Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Plaque Psoriasis Treatment Medications Sales Market Share by Application (2021-2032)
  4. 7.2 Global Plaque Psoriasis Treatment Medications Revenue by Application (2021-2032)
  5. 7.2.1 Global Plaque Psoriasis Treatment Medications Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Plaque Psoriasis Treatment Medications Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Plaque Psoriasis Treatment Medications Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Plaque Psoriasis Treatment Medications Value Chain Analysis
  2. 8.1.1 Plaque Psoriasis Treatment Medications Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Plaque Psoriasis Treatment Medications Production Mode & Process
  5. 8.2 Plaque Psoriasis Treatment Medications Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Plaque Psoriasis Treatment Medications Distributors
  8. 8.2.3 Plaque Psoriasis Treatment Medications Customers
9 Global Plaque Psoriasis Treatment Medications Analyzing Market Dynamics
  1. 9.1 Plaque Psoriasis Treatment Medications Industry Trends
  2. 9.2 Plaque Psoriasis Treatment Medications Industry Drivers
  3. 9.3 Plaque Psoriasis Treatment Medications Industry Opportunities and Challenges
  4. 9.4 Plaque Psoriasis Treatment Medications Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst